Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1995 Jan;88(1):35P–39P.

The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.

J K Field 1
PMCID: PMC1295074  PMID: 7884768

Full text

PDF
35P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra E., Garozzo A., Grillo A., Catalano G. B. Cytogenetic alterations in laryngeal carcinomas. Arch Otolaryngol Head Neck Surg. 1992 Dec;118(12):1320–1322. doi: 10.1001/archotol.1992.01880120046009. [DOI] [PubMed] [Google Scholar]
  2. Arnold A., Kim H. G., Gaz R. D., Eddy R. L., Fukushima Y., Byers M. G., Shows T. B., Kronenberg H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest. 1989 Jun;83(6):2034–2040. doi: 10.1172/JCI114114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  4. Bishop J. M. The molecular genetics of cancer. Science. 1987 Jan 16;235(4786):305–311. doi: 10.1126/science.3541204. [DOI] [PubMed] [Google Scholar]
  5. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  6. Brachman D. G., Graves D., Vokes E., Beckett M., Haraf D., Montag A., Dunphy E., Mick R., Yandell D., Weichselbaum R. R. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 1992 Sep 1;52(17):4832–4836. [PubMed] [Google Scholar]
  7. Bártek J., Bártková J., Vojtesek B., Stasková Z., Lukás J., Rejthar A., Kovarík J., Midgley C. A., Gannon J. V., Lane D. P. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991 Sep;6(9):1699–1703. [PubMed] [Google Scholar]
  8. Cerutti P. A., Trump B. F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells. 1991 Jan;3(1):1–7. [PubMed] [Google Scholar]
  9. Chang S. E., Bhatia P., Johnson N. W., Morgan P. R., McCormick F., Young B., Hiorns L. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer. 1991 May 30;48(3):409–412. doi: 10.1002/ijc.2910480318. [DOI] [PubMed] [Google Scholar]
  10. Chiba I., Takahashi T., Nau M. M., D'Amico D., Curiel D. T., Mitsudomi T., Buchhagen D. L., Carbone D., Piantadosi S., Koga H. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. 1990 Oct;5(10):1603–1610. [PubMed] [Google Scholar]
  11. Cowan J. M. Cytogenetics in head and neck cancer. Otolaryngol Clin North Am. 1992 Oct;25(5):1073–1087. [PubMed] [Google Scholar]
  12. Farmer G., Bargonetti J., Zhu H., Friedman P., Prywes R., Prives C. Wild-type p53 activates transcription in vitro. Nature. 1992 Jul 2;358(6381):83–86. doi: 10.1038/358083a0. [DOI] [PubMed] [Google Scholar]
  13. Field J. K. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):67–76. doi: 10.1016/0964-1955(92)90016-t. [DOI] [PubMed] [Google Scholar]
  14. Field J. K., Spandidos D. A. Expression of oncogenes in human tumours with special reference to the head and neck region. J Oral Pathol. 1987 Mar;16(3):97–107. doi: 10.1111/j.1600-0714.1987.tb01474.x. [DOI] [PubMed] [Google Scholar]
  15. Field J. K., Spandidos D. A., Malliri A., Gosney J. R., Yiagnisis M., Stell P. M. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991 Sep;64(3):573–577. doi: 10.1038/bjc.1991.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Field J. K., Spandidos D. A., Stell P. M. Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking. Lancet. 1992 Feb 22;339(8791):502–503. doi: 10.1016/0140-6736(92)91122-o. [DOI] [PubMed] [Google Scholar]
  17. Field J. K., Spandidos D. A., Stell P. M., Vaughan E. D., Evan G. I., Moore J. P. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene. 1989 Dec;4(12):1463–1468. [PubMed] [Google Scholar]
  18. Field J. K., Spandidos D. A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res. 1990 Jan-Feb;10(1):1–22. [PubMed] [Google Scholar]
  19. Field J. K., Spandidos D. A., Yiagnisis M., Gosney J. R., Papadimitriou K., Stell P. M. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res. 1992 May-Jun;12(3):613–619. [PubMed] [Google Scholar]
  20. Field J. K., Yiagnisis M., Spandidos D. A., Gosney J. R., Papadimitriou K., Vaughan E. D., Stell P. M. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. Eur J Surg Oncol. 1992 Apr;18(2):168–176. [PubMed] [Google Scholar]
  21. Field J. K., Zoumpourlis V., Spandidos D. A., Jones A. S. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. Cancer Detect Prev. 1994;18(3):197–208. [PubMed] [Google Scholar]
  22. Gaudray P., Szepetowski P., Escot C., Birnbaum D., Theillet C. DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutat Res. 1992 May;276(3):317–328. doi: 10.1016/0165-1110(92)90018-5. [DOI] [PubMed] [Google Scholar]
  23. Gusterson B. A., Anbazhagan R., Warren W., Midgely C., Lane D. P., O'Hare M., Stamps A., Carter R., Jayatilake H. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 1991 Oct;6(10):1785–1789. [PubMed] [Google Scholar]
  24. Hauser-Urfer I. H., Stauffer J. Comparative chromosome analysis of nine squamous cell carcinoma lines from tumors of the head and neck. Cytogenet Cell Genet. 1985;39(1):35–39. doi: 10.1159/000132100. [DOI] [PubMed] [Google Scholar]
  25. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  26. Howell R. E., Wong F. S., Fenwick R. G. Loss of Harvey ras heterozygosity in oral squamous carcinoma. J Oral Pathol Med. 1989 Feb;18(2):79–83. doi: 10.1111/j.1600-0714.1989.tb00741.x. [DOI] [PubMed] [Google Scholar]
  27. Ishitoya J., Toriyama M., Oguchi N., Kitamura K., Ohshima M., Asano K., Yamamoto T. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer. 1989 Apr;59(4):559–562. doi: 10.1038/bjc.1989.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  29. Langdon J. D., Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg. 1992 Aug;30(4):214–220. doi: 10.1016/0266-4356(92)90263-i. [DOI] [PubMed] [Google Scholar]
  30. Latif F., Fivash M., Glenn G., Tory K., Orcutt M. L., Hampsch K., Delisio J., Lerman M., Cowan J., Beckett M. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res. 1992 Mar 15;52(6):1451–1456. [PubMed] [Google Scholar]
  31. Leonard J. H., Kearsley J. H., Chenevix-Trench G., Hayward N. K. Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer. 1991 Jun 19;48(4):511–515. doi: 10.1002/ijc.2910480406. [DOI] [PubMed] [Google Scholar]
  32. Merritt W. D., Weissler M. C., Turk B. F., Gilmer T. M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1990 Dec;116(12):1394–1398. doi: 10.1001/archotol.1990.01870120040005. [DOI] [PubMed] [Google Scholar]
  33. Motokura T., Bloom T., Kim H. G., Jüppner H., Ruderman J. V., Kronenberg H. M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991 Apr 11;350(6318):512–515. doi: 10.1038/350512a0. [DOI] [PubMed] [Google Scholar]
  34. Ogden G. R., Kiddie R. A., Lunny D. P., Lane D. P. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol. 1992 Apr;166(4):389–394. doi: 10.1002/path.1711660411. [DOI] [PubMed] [Google Scholar]
  35. Oliner J. D., Kinzler K. W., Meltzer P. S., George D. L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992 Jul 2;358(6381):80–83. doi: 10.1038/358080a0. [DOI] [PubMed] [Google Scholar]
  36. Owens W., Field J. K., Howard P. J., Stell P. M. Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):17–21. doi: 10.1016/0964-1955(92)90006-m. [DOI] [PubMed] [Google Scholar]
  37. Parkin D. M., Lärä E., Muir C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988 Feb 15;41(2):184–197. doi: 10.1002/ijc.2910410205. [DOI] [PubMed] [Google Scholar]
  38. Pavelic Z. P., Gluckman J. L., Gapany M., Reising J., Craven J. M., Kelley D. J., Pavelic L., Gapany S., Biddinger P., Stambrook P. J. Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res. 1992 Sep-Oct;12(5):1389–1394. [PubMed] [Google Scholar]
  39. Pines J. Cyclins: wheels within wheels. Cell Growth Differ. 1991 Jun;2(6):305–310. [PubMed] [Google Scholar]
  40. Porter M. J., Field J. K., Leung S. F., Lo D., Lee J. C., Spandidos D. A., van Hasselt C. A. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol. 1994 Jan;114(1):105–109. doi: 10.3109/00016489409126025. [DOI] [PubMed] [Google Scholar]
  41. Rumsby G., Carter R. L., Gusterson B. A. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer. 1990 Mar;61(3):365–368. doi: 10.1038/bjc.1990.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sakai E., Rikimaru K., Ueda M., Matsumoto Y., Ishii N., Enomoto S., Yamamoto H., Tsuchida N. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer. 1992 Dec 2;52(6):867–872. doi: 10.1002/ijc.2910520606. [DOI] [PubMed] [Google Scholar]
  43. Sakai E., Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 1992 May;7(5):927–933. [PubMed] [Google Scholar]
  44. Saranath D., Bhoite L. T., Mehta A. R., Sanghavi V., Deo M. G. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas. J Cancer Res Clin Oncol. 1991;117(5):484–488. doi: 10.1007/BF01612771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Saranath D., Chang S. E., Bhoite L. T., Panchal R. G., Kerr I. B., Mehta A. R., Johnson N. W., Deo M. G. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer. 1991 Apr;63(4):573–578. doi: 10.1038/bjc.1991.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Saranath D., Panchal R. G., Nair R., Mehta A. R., Sanghavi V., Sumegi J., Klein G., Deo M. G. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res. 1989 May;80(5):430–437. doi: 10.1111/j.1349-7006.1989.tb02332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sauter E. R., Ridge J. A., Gordon J., Eisenberg B. L. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg. 1992 Dec;164(6):651–653. doi: 10.1016/s0002-9610(05)80727-5. [DOI] [PubMed] [Google Scholar]
  48. Sheng Z. M., Barrois M., Klijanienko J., Micheau C., Richard J. M., Riou G. Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer. 1990 Sep;62(3):398–404. doi: 10.1038/bjc.1990.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Somers K. D., Merrick M. A., Lopez M. E., Incognito L. S., Schechter G. L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992 Nov 1;52(21):5997–6000. [PubMed] [Google Scholar]
  50. Stell P. M., McCormick M. S. Cancer of the head and neck: are we doing any better? Lancet. 1985 Nov 16;2(8464):1127–1127. doi: 10.1016/s0140-6736(85)90717-2. [DOI] [PubMed] [Google Scholar]
  51. Varley J. M., Swallow J. E., Brammar W. J., Whittaker J. L., Walker R. A. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. 1987;1(4):423–430. [PubMed] [Google Scholar]
  52. Volling P., Jungehülsing M., Jücker M., Stützer H., Diehl V., Tesch H. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck. Eur J Cancer. 1993;29A(3):383–389. doi: 10.1016/0959-8049(93)90392-s. [DOI] [PubMed] [Google Scholar]
  53. Warnakulasuriya K. A., Chang S. E., Johnson N. W. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases. J Oral Pathol Med. 1992 May;21(5):225–229. doi: 10.1111/j.1600-0714.1992.tb00106.x. [DOI] [PubMed] [Google Scholar]
  54. Watling D. L., Gown A. M., Coltrera M. D. Overexpression of p53 in head and neck cancer. Head Neck. 1992 Nov-Dec;14(6):437–444. doi: 10.1002/hed.2880140603. [DOI] [PubMed] [Google Scholar]
  55. Yin Y., Tainsky M. A., Bischoff F. Z., Strong L. C., Wahl G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992 Sep 18;70(6):937–948. doi: 10.1016/0092-8674(92)90244-7. [DOI] [PubMed] [Google Scholar]
  56. Yokota J., Tsukada Y., Nakajima T., Gotoh M., Shimosato Y., Mori N., Tsunokawa Y., Sugimura T., Terada M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res. 1989 Jul 1;49(13):3598–3601. [PubMed] [Google Scholar]
  57. Zaslav A. L., Stamberg J., Steinberg B. M., Lin Y. J., Abramson A. Cytogenetic analysis of head and neck carcinomas. Cancer Genet Cytogenet. 1991 Oct 15;56(2):181–187. doi: 10.1016/0165-4608(91)90169-u. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES